Relmada Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Stock Information for Relmada Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.